StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30988% above fair value
$32.16+2.64 (+8.94%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Harrow shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Harrow's shares outstanding was 37M at Jun 30, 2026. For fiscal 2025 it was 37M, up 3.1% from the year before. Over ten years it grew 14.4% a year on average. The highest annual figure on record is 37M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202537M+3.1%
FY2024Dec 31, 202436M+9.3%
FY2023Dec 31, 202333M+18.8%
FY2022Dec 31, 202227M+2.6%
FY2021Dec 31, 202127M+3.3%
FY2020Dec 31, 202026M-2.2%
FY2019Dec 31, 201926M+11.1%
FY2018Dec 31, 201824M+18.9%
FY2017Dec 31, 201720M+57.2%
FY2016Dec 31, 201613M+33.1%
FY2015Dec 31, 201510M+4.9%
FY2014Dec 31, 20149M+5.5%
FY2013Dec 31, 20139M+92.7%
FY2012Dec 31, 20124M+1029.6%
FY2011Dec 31, 20110M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202637M-3.9%
Q1 FY2026Mar 31, 202637M+3.9%
Q4 FY2025Dec 31, 202537M+4.1%
Q3 FY2025Sep 30, 202539M+8.9%
Q2 FY2025Jun 30, 202539M+9.1%
Q1 FY2025Mar 31, 202536M+1.0%
Q4 FY2024Dec 31, 202436M+1.2%
Q3 FY2024Sep 30, 202436M+4.2%
Q2 FY2024Jun 30, 202436M+16.9%
Q1 FY2024Mar 31, 202435M+17.1%
Q4 FY2023Dec 31, 202335M+26.6%
Q3 FY2023Sep 30, 202334M+25.2%
Q2 FY2023Jun 30, 202330M+11.6%
Q1 FY2023Mar 31, 202330M+11.2%
Q4 FY2022Dec 31, 202228M+3.0%
Q3 FY2022Sep 30, 202227M+0.9%
Q2 FY2022Jun 30, 202227M+2.1%
Q1 FY2022Mar 31, 202227M-0.9%
Q4 FY2021Dec 31, 202127M+4.7%
Q3 FY2021Sep 30, 202127M+0.1%
Q2 FY2021Jun 30, 202127M+3.3%
Q1 FY2021Mar 31, 202127M+6.2%
Q4 FY2020Dec 31, 202026M-14.2%
Q3 FY2020Sep 30, 202027M+5.9%
Q2 FY2020Jun 30, 202026M+2.7%
Q1 FY2020Mar 31, 202026M-2.7%
Q4 FY2019Dec 31, 201930M-3.7%
Q3 FY2019Sep 30, 201926M+17.8%
Q2 FY2019Jun 30, 201925M+8.8%
Q1 FY2019Mar 31, 201927M+26.9%
Q4 FY2018Dec 31, 201831M+51.8%
Q3 FY2018Sep 30, 201822M+7.1%
Q2 FY2018Jun 30, 201823M-0.0%
Q1 FY2018Mar 31, 201821M+10.7%
Q4 FY2017Dec 31, 201721M+50.4%
Q3 FY2017Sep 30, 201720M+50.5%
Q2 FY2017Jun 30, 201723M–
Q1 FY2017Mar 31, 201719M–
Q4 FY2016Dec 31, 201614M–
Q3 FY2016Sep 30, 201613M–

More Harrow figures

See a number that looks wrong?